Medical marijuana manufacturers prepare to open

Published 10:21 am Wednesday, March 11, 2015

By Riham Feshir news/90.1

Minnesota medical marijuana manufacturers have lined up several dispensary sites throughout state and are set to have the first harvest over the next few weeks.

Email newsletter signup

In Minneapolis, construction is under way on the city’s first dispensary – a standalone 100-year-old downtown building that once housed the League of Catholic Women. This summer, it is expected to be one company’s flagship dispensary.

The state Department of Health has approved two manufacturers, LeafLine Labs and Minnesota Medical Solutions, also known as MinnMed, to grow, process and sell medical cannabis in pill or oil form to Minnesotans starting July 1.

Each manufacturer is allowed four distribution centers around the state. MinnMed may locate dispensaries only in odd numbered Minnesota congressional districts and LeafLine Labs in the even numbered districts. The people allowed to purchase medicinal cannabis must have one of the 10 medical conditions specified by the state.

LeafLine is taking a measured approach. The medical cannabis company that includes members of the Bachman floral and garden store family, expects to open its first site in Eagan July 1. The other dispensaries in St. Paul, St. Cloud and Hibbing will open as the number of registered patients grows.

MinnMed, on the other hand, has all four sites lined up with target opening dates in July and August. The company will start remodeling a dispensary in a Rochester strip mall over the next few weeks. The company expects to close on a property in Moorhead for its third site and likely will open the fourth either in Minnetonka or Eden Prairie by August.

“It’s about patient access and we can’t have just one site and expect the whole state to come there,” MinnMed CEO Kyle Kingsley said. “It was important to us that we do our best to be aggressive.”

LeafLine Labs cofounder and medical director Gary Starr said selected dispensary sites were not “pure choice, but also based on availability.”

The law eliminates a lot of possibilities. No dispensary could stand closer than 1,000 feet to public or private schools. Distribution facilities also must be spread throughout the state to improve patient access.

Starr, whose company was chosen in early December, said the compressed timeline forced the company to make location decisions based on relatively quick conversations with local officials, at least those willing to have the conversation in the first place.

A number of Twin Cities western suburbs and Duluth passed six- to 12-month moratoriums to stop dispensaries from coming to their cities, citing the need for additional studies to possibly update zoning requirements.

Medical marijuana advocate Patrick McClellan said he thought he was done lobbying for the drug until he stood before Bloomington city leaders in January to ask them not to pass a moratorium on distribution and manufacturing.

“People in my position and people who are terminally ill don’t need any more obstacles to get medication that the state says is now legal,” said McClellan, who suffers from adult onset muscular dystrophy.